在纤维肌痛管理当前的概念和治疗选择
Nathan Li1, Joshua Cooper2, Tanisha Fleming3
1Li, BS, Medical College of Wisconsin - Milwaukee, Milwaukee, WI, USA.
Psychopharmacology bulletin
|March 13, 2026
概括
纤维肌痛综合征是一种复杂的慢性疼痛状况. 研究正在探索其原因,诊断和治疗,由于其多方面的性质,这些仍然具有挑战性.
科学领域:
- 风湿病学和疼痛医学
- 神经科学是一个神经科学.
- 遗传学和表观遗传学
背景情况:
- 纤维肌痛综合征 (FMS) 是一种复杂的慢性疼痛疾病.
- 它呈现出广泛的疼痛,疲劳和认知困难.
- FMS的确切病理生理学尚未完全理解.
研究的目的:
- 审查目前对纤维肌痛综合征的理解.
- 讨论它的流行病学,病理生理学和临床表现.
- 概述当前和新兴的治疗策略.
主要方法:
- 对流行病学数据的文献综述.
- 关于神经成像,遗传学和微生物组的研究摘要.
- 诊断标准的分析演变.
- 多学科治疗方法的概述.
主要成果:
- 纤维肌痛的诊断和治疗仍然是临床医生面临的挑战.
- 目前正在进行的研究表明,了解FMS病理生理学是有前途的.
- 不断发展的诊断标准旨在更好地识别患者.
结论:
- 纤维肌痛综合征需要一个多学科的方法来有效管理.
- 对其复杂的病理生理学的进一步研究至关重要.
- 持续完善诊断标准将有助于临床实践.
相关概念视频
Myasthenia Gravis: Overview and Treatment
3.3K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
3.3K
Analgesia and Pain Management
2.7K
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
2.7K
Inflammatory Bowel Disease IV: Pharmacological Management
893
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
893
Irritable Bowel Syndrome III: Medical and Nursing Management
959
Managing Irritable Bowel Syndrome (IBS) involves a multifaceted approach, including lifestyle modifications, dietary changes, and medication.
959
Cystic Fibrosis: Management
601
Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
Sinus disease and chronic...
601
Peripheral Artery Disease III: Interprofessional Care
494
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
494


